Tag Archives: ADMA Biologics

ADMA Biologics (ADMA) Receives a Rating Update from a Top Analyst

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on ADMA Biologics (ADMA – Research Report) today and set a price target of $12.00. The company’s shares closed last Monday at $2.88. According to TipRanks.com, Selvaraju is a top 100

ADMA Biologics (ADMA) Gets a Buy Rating from Maxim Group

Maxim Group analyst Jason McCarthy assigned a Buy rating to ADMA Biologics (ADMA – Research Report) today and set a price target of $6.00. The company’s shares closed last Friday at $2.84. According to TipRanks.com, McCarthy is a 5-star analyst

Oppenheimer Keeps a Buy Rating on ADMA Biologics (ADMA)

Oppenheimer analyst Leland Gershell maintained a Buy rating on ADMA Biologics (ADMA – Research Report) today and set a price target of $7.00. The company’s shares closed last Wednesday at $3.20. According to TipRanks.com, Gershell is a 5-star analyst with

ADMA Biologics (ADMA) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on ADMA Biologics (ADMA – Research Report) today and set a price target of $12.00. The company’s shares closed last Monday at $2.16, close to its 52-week low of $1.76. According

Analysts Are Bullish on Top Healthcare Stocks: ADMA Biologics (ADMA), SmileDirectClub (SDC)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ADMA Biologics (ADMA – Research Report) and SmileDirectClub (SDC – Research Report) with bullish sentiments. ADMA Biologics (ADMA) H.C. Wainwright analyst Ram

ADMA Biologics (ADMA) Gets a Buy Rating from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on ADMA Biologics (ADMA – Research Report), with a price target of $13.00. The company’s shares closed last Monday at $4.30. According to TipRanks.com, Selvaraju has